-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
-
Summary
-
Advanced Biomed Inc. quarterly and annual Research and Development Expense in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
- Advanced Biomed Inc. Research and Development Expense for the quarter ending 31 Dec 2025 was $186,331, a 12% decline year-over-year.
- Advanced Biomed Inc. Research and Development Expense for the twelve months ending 31 Dec 2025 was $937,994.
- Advanced Biomed Inc. annual Research and Development Expense for 2025 was $909,771, a 3.4% increase from 2024.